Los Angeles, Calif., October
29, 2007
Elekta, a global leader in radiation oncology and non-invasive
neurosurgery solutions, announced Elekta Infinity*, the
definitive new digital linear accelerator optimized for
delivering Volumetric Intensity Modulated Arc Therapy* (VMAT), a
very fast Intensity Modulated Radiation Therapy (IMRT) treatment
delivered in single or multiple arcs, at the 49th Annual Meeting
of The American Society for Therapeutic Radiology and Oncology
(ASTRO). The meeting is being held October 28-November 1, at the
Los Angeles Convention Center.
In the Elekta booth, Jay Hoey, Executive Vice President Product
Creation at Elekta and CEO of IMPAC Medical Systems, announced
the new Elekta Infinity, which more precisely targets tumors and
protects surrounding healthy tissue, while drastically reducing
radiation therapy treatment times.
“Elekta is committed to fighting serious disease and improving
quality of life,” says Hoey. “The Elekta Infinity with VMAT
demonstrates this by benefiting patients with dramatically
shorter treatment times and highly precise tumor targeting.”
Elekta VMAT improves on IMRT technology
Utilizing Elekta’s VMAT solution greatly improves on existing
IMRT technologies and offers a faster alternative to helical
tomotherapy. Elekta’s VMAT solution, when used with Elekta
Infinity, varies the radiation beam during treatment by
simultaneously manipulating the gantry position and speed, MLC
leaves, dose rate and collimator angle.
This provides several distinct advantages over current IMRT
techniques, specifically the ability to deliver more radiation
to the target while sparing healthy tissue in significantly less
time than existing therapies. In addition, Elekta Infinity
combines VMAT with VolumeView™ 3D cone beam imaging to create
high-contrast images with ultra-low dose.
Patients benefit from faster treatments, reduced radiation
Elekta Infinity allows for a total VMAT treatment session in no
more than five minutes, including true VolumeView™ 3D cone beam
images in three minutes and two minutes of highly conformal arc
delivery of radiation. Head and neck treatments – including
daily 3D imaging – can be delivered in less than five minutes
with Elekta Infinity. Coupled with the Elekta Infinity system’s
clinically proven ultra-low 3D imaging dose, the speed of VMAT
treatments can reduce the whole body dose of patients receiving
treatment. Elekta Infinity also protects patients with real-time
control point to control point monitoring throughout the
process.
Due to the ability of Elekta Infinity to also treat in
non-coplanar angles and non trans-axial planes, the system can
yield similar or improved dosimetric performance compared to
helical tomotherapy.
More solutions from Elekta
In addition to Elekta Infinity, Elekta is exhibiting other
solutions for boosting clinical efficiency at ASTRO. Elekta’s
complete stereotactic portfolio is featured, as well as
innovative and time-saving products from the Elekta Group.
*Elekta Infinity and Volumetric Intensity Modulated Arc Therapy
(VMAT) from Elekta are works in progress and not yet available
for sale or distribution
About Elekta
Elekta is an international medical technology group, providing
oncologists, radiation therapists, neurosurgeons and many other
medical specialists with state of the art tools to fight serious
disease.
Elekta provides advanced clinical solutions, comprehensive
management and information systems as well as services for
improved cancer care and management of brain disorders.
Elekta’s systems and solutions are used in over 4,500 hospitals
around the world. Clinical and information management solutions
include, among others, Leksell Gamma Knife® for non-invasive
treatment of brain disorders, Elekta Axesse™ and Elekta Synergy®
for stereotactic and image guided radiation therapy and
radiosurgery as well as the MOSAIQ™ suite of software for
image-enabled EMR and efficient management of clinical and
patient data.
With more than 2,000 employees globally, the corporate
headquarter is located in Stockholm, Sweden and the company is
listed on the Nordic Exchange under the ticker EKTAb. More
information about Elekta can be found at www.elekta.com. |
|
Media Inquiries:
Michelle Lee
PR and Advertising Manager
Tel: +1 770-670-2447
michelle.lee@elekta.com
Global Marketing inquiries: Peter Gaccione
Vice President,
Global Marketing
Tel: +1 770-670-2380
peter.gaccione@elekta.com
Investor inquiries:
Peter Ejemyr
Group VP,
Corporate Communications, Tel: +46 733 611 000
peter.ejemyr@elekta.com
Link Disclaimer
|
